{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:48:52Z","timestamp":1793216932400,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8038","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,11,14]]},"DOI":"10.1038\/s41586-024-08033-4","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:03:44Z","timestamp":1729080224000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":201,"title":["Probiotic neoantigen delivery vectors for precision cancer immunotherapy"],"prefix":"10.1038","volume":"635","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3802-4927","authenticated-orcid":false,"given":"Andrew","family":"Redenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-2770","authenticated-orcid":false,"given":"Jongwon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Redenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeren","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice R.","family":"Gurbatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0329-7204","authenticated-orcid":false,"given":"Meghna","family":"Komaranchath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1479-7432","authenticated-orcid":false,"given":"YoungUk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseung","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Ballister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa L.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vardoshivilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2713-7659","authenticated-orcid":false,"given":"Tal","family":"Danino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0657-0528","authenticated-orcid":false,"given":"Nicholas","family":"Arpaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"8033_CR1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","volume":"598","author":"FP Canale","year":"2021","unstructured":"Canale, F. P. et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature 598, 662\u2013666 (2021).","journal-title":"Nature"},{"key":"8033_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.abp9563","volume":"380","author":"YE Chen","year":"2023","unstructured":"Chen, Y. E. et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science 380, 203\u2013210 (2023).","journal-title":"Science"},{"key":"8033_CR3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980 (2020).","journal-title":"Science"},{"key":"8033_CR4","first-page":"4537","volume":"57","author":"JM Pawelek","year":"1997","unstructured":"Pawelek, J. M., Low, K. B. & Bermudes, D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57, 4537\u20134544 (1997).","journal-title":"Cancer Res."},{"key":"8033_CR5","doi-asserted-by":"publisher","unstructured":"Naghavian, R. et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma. Nature https:\/\/doi.org\/10.1038\/s41586-023-06081-w (2023).","DOI":"10.1038\/s41586-023-06081-w"},{"key":"8033_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora, S. et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature 592, 138\u2013143 (2021).","journal-title":"Nature"},{"key":"8033_CR7","doi-asserted-by":"crossref","unstructured":"Stark, J. C. et al. On-demand biomanufacturing of protective conjugate vaccines. Sci. Adv. 7, eabe9444 (2021).","DOI":"10.1126\/sciadv.abe9444"},{"key":"8033_CR8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343\u2013353 (2015).","journal-title":"Nat. Immunol."},{"key":"8033_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69\u201374 (2015).","journal-title":"Science"},{"key":"8033_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222\u2013226 (2017).","journal-title":"Nature"},{"key":"8033_CR11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas, L. A. et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618, 144\u2013150 (2023).","journal-title":"Nature"},{"key":"8033_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"8033_CR13","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","volume":"185","author":"MC Sellars","year":"2022","unstructured":"Sellars, M. C., Wu, C. J. & Fritsch, E. F. Cancer vaccines: building a bridge over troubled waters. Cell 185, 2770\u20132788 (2022).","journal-title":"Cell"},{"key":"8033_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","volume":"8","author":"J Hundal","year":"2020","unstructured":"Hundal, J. et al. pVACtools: a computational toolkit to identify and visualize cancer neoantigens. Cancer Immunol. Res. 8, 409\u2013420 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"8033_CR15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520, 692\u2013696 (2015).","journal-title":"Nature"},{"key":"8033_CR16","doi-asserted-by":"crossref","first-page":"e001111","DOI":"10.1136\/jitc-2020-001111","volume":"8","author":"MY Lee","year":"2020","unstructured":"Lee, M. Y., Jeon, J. W., Sievers, C. & Allen, C. T. Antigen processing and presentation in cancer immunotherapy. J. Immunother. Cancer 8, e001111 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"8033_CR17","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.20141308","volume":"211","author":"F Duan","year":"2014","unstructured":"Duan, F. et al. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. J. Exp. Med. 211, 2231\u20132248 (2014).","journal-title":"J. Exp. Med."},{"key":"8033_CR18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach, E. et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574, 696\u2013701 (2019).","journal-title":"Nature"},{"key":"8033_CR19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","volume":"618","author":"B Kruse","year":"2023","unstructured":"Kruse, B. et al. CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours. Nature 618, 1033\u20131040 (2023).","journal-title":"Nature"},{"key":"8033_CR20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","volume":"183","author":"DK Wells","year":"2020","unstructured":"Wells, D. K. et al. Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction. Cell 183, 818\u2013834.e13 (2020).","journal-title":"Cell"},{"key":"8033_CR21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.169.1.350","volume":"169","author":"S Zwaveling","year":"2002","unstructured":"Zwaveling, S. et al. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J. Immunol. 169, 350\u2013358 (2002).","journal-title":"J. Immunol."},{"key":"8033_CR22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.isci.2019.03.019","volume":"14","author":"AJH Fedorec","year":"2019","unstructured":"Fedorec, A. J. H. et al. Two new plasmid post-segregational killing mechanisms for the implementation of synthetic gene networks in Escherichia coli. iScience 14, 323\u2013334 (2019).","journal-title":"iScience"},{"key":"8033_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.1997.tb00969.x","volume":"156","author":"RM Zinkernagel","year":"1997","unstructured":"Zinkernagel, R. M. et al. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156, 199\u2013209 (1997).","journal-title":"Immunol. Rev."},{"key":"8033_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ni1559","volume":"9","author":"SE Henrickson","year":"2008","unstructured":"Henrickson, S. E. et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat. Immunol. 9, 282\u2013291 (2008).","journal-title":"Nat. Immunol."},{"key":"8033_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.immunol.17.1.51","volume":"17","author":"JW Yewdell","year":"1999","unstructured":"Yewdell, J. W. & Bennink, J. R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17, 51\u201388 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"8033_CR26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jmb.2009.09.022","volume":"394","author":"P Daegelen","year":"2009","unstructured":"Daegelen, P., Studier, F. W., Lenski, R. E., Cure, S. & Kim, J. F. Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21(DE3). J. Mol. Biol. 394, 634\u2013643 (2009).","journal-title":"J. Mol. Biol."},{"key":"8033_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/acssynbio.0c00466","volume":"10","author":"A Kan","year":"2021","unstructured":"Kan, A., Gelfat, I., Emani, S., Praveschotinunt, P. & Joshi, N. S. Plasmid vectors for in vivo selection-free use with the probiotic E. coli Nissle 1917. ACS Synth. Biol. 10, 94\u2013106 (2021).","journal-title":"ACS Synth. Biol."},{"key":"8033_CR28","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1128\/jb.175.23.7617-7623.1993","volume":"175","author":"TA Russo","year":"1993","unstructured":"Russo, T. A. & Singh, G. An extraintestinal, pathogenic isolate of Escherichia coli (O4\/K54\/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide. J. Bacteriol. 175, 7617\u20137623 (1993).","journal-title":"J. Bacteriol."},{"key":"8033_CR29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/dnares\/dsm024","volume":"14","author":"ETE Niba","year":"2007","unstructured":"Niba, E. T. E., Naka, Y., Nagase, M., Mori, H. & Kitakawa, M. A genome-wide approach to identify the genes involved in biofilm formation in E. coli. DNA Res. 14, 237\u2013246 (2007).","journal-title":"DNA Res."},{"key":"8033_CR30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fmicb.2015.00063","volume":"6","author":"R Riva","year":"2015","unstructured":"Riva, R., Korhonen, T. K. & Meri, S. The outer membrane protease PgtE of Salmonella enterica interferes with the alternative complement pathway by cleaving factors B and H. Front. Microbiol. 6, 63 (2015).","journal-title":"Front. Microbiol."},{"key":"8033_CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/AAC.45.4.999-1007.2001","volume":"45","author":"K Lewis","year":"2001","unstructured":"Lewis, K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45, 999\u20131007 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8033_CR32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1365-2958.1999.01272.x","volume":"31","author":"DE Higgins","year":"1999","unstructured":"Higgins, D. E., Shastri, N. & Portnoy, D. A. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol. Microbiol. 31, 1631\u20131641 (1999).","journal-title":"Mol. Microbiol."},{"key":"8033_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/CVI.00488-12","volume":"20","author":"A Wallecha","year":"2013","unstructured":"Wallecha, A. et al. Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability. Clin. Vaccine Immunol. 20, 77\u201384 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"8033_CR34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2008.09.017","volume":"29","author":"S-J Kang","year":"2008","unstructured":"Kang, S.-J., Liang, H.-E., Reizis, B. & Locksley, R. M. Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity 29, 819\u2013833 (2008).","journal-title":"Immunity"},{"key":"8033_CR35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2249.2005.02922.x","volume":"142","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto, K. et al. Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells. Clin. Exp. Immunol. 142, 268\u2013274 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"8033_CR36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/82717","volume":"1","author":"DP Harris","year":"2000","unstructured":"Harris, D. P. et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1, 475\u2013482 (2000).","journal-title":"Nat. Immunol."},{"key":"8033_CR37","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.1602107","volume":"199","author":"Q Ding","year":"2017","unstructured":"Ding, Q., Mohib, K., Kuchroo, V. K. & Rothstein, D. M. TIM-4 identifies IFN-\u03b3-expressing proinflammatory B effector 1 cells that promote tumor and allograft rejection. J. Immunol. 199, 2585\u20132595 (2017).","journal-title":"J. Immunol."},{"key":"8033_CR38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"CL Vanderlugt","year":"2002","unstructured":"Vanderlugt, C. L. & Miller, S. D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2, 85\u201395 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"8033_CR39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253\u2013268 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"8033_CR40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13046-015-0256-0","volume":"34","author":"G He","year":"2015","unstructured":"He, G. et al. Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1\/PD-1 signalling pathway in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 34, 141 (2015).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"8033_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka, A. & Sakaguchi, S. Regulatory T cells in cancer immunotherapy. Cell Res. 27, 109\u2013118 (2017).","journal-title":"Cell Res."},{"key":"8033_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2172-12-43","volume":"12","author":"B Wang","year":"2011","unstructured":"Wang, B. et al. Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol. 12, 43 (2011).","journal-title":"BMC Immunol."},{"key":"8033_CR43","volume":"11","author":"Q Peng","year":"2020","unstructured":"Peng, Q. et al. PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. Nat. Commun. 11, 4835 (2020).","journal-title":"Nat. Commun."},{"key":"8033_CR44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","volume":"619","author":"L Bod","year":"2023","unstructured":"Bod, L. et al. B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature 619, 348\u2013356 (2023).","journal-title":"Nature"},{"key":"8033_CR45","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","volume":"153","author":"A Sette","year":"1994","unstructured":"Sette, A. et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5586\u20135592 (1994).","journal-title":"J. Immunol."},{"key":"8033_CR46","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","volume":"7","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg, M. et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. 7, 13404 (2016).","journal-title":"Nat. Commun."},{"key":"8033_CR47","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aad1253","volume":"350","author":"E Tran","year":"2015","unstructured":"Tran, E. et al. Immunogenicity of somatic mutations in human gastrointestinal cancers. Science 350, 1387\u20131390 (2015).","journal-title":"Science"},{"key":"8033_CR48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.1901173","volume":"205","author":"A Sachs","year":"2020","unstructured":"Sachs, A. et al. Impact of cysteine residues on MHC binding predictions and recognition by tumor-reactive T cells. J. Immunol. 205, 539\u2013549 (2020).","journal-title":"J. Immunol."},{"key":"8033_CR49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41541-020-00253-9","volume":"5","author":"CA Arbelaez","year":"2020","unstructured":"Arbelaez, C. A. et al. A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses. NPJ Vaccines 5, 106 (2020).","journal-title":"NPJ Vaccines"},{"key":"8033_CR50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10594-2","volume":"10","author":"AM D\u2019Alise","year":"2019","unstructured":"D\u2019Alise, A. M. et al. Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade. Nat. Commun. 10, 2688 (2019).","journal-title":"Nat. Commun."},{"key":"8033_CR51","doi-asserted-by":"crossref","first-page":"1771925","DOI":"10.1080\/2162402X.2020.1771925","volume":"9","author":"N Salomon","year":"2020","unstructured":"Salomon, N. et al. A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. OncoImmunology 9, 1771925 (2020).","journal-title":"OncoImmunology"},{"key":"8033_CR52","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","volume":"17","author":"SA Rosenberg","year":"2011","unstructured":"Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550\u20134557 (2011).","journal-title":"Clin. Cancer Res."},{"key":"8033_CR53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1126\/science.aay5967","volume":"367","author":"K Reinhard","year":"2020","unstructured":"Reinhard, K. et al. An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors. Science 367, 446\u2013453 (2020).","journal-title":"Science"},{"key":"8033_CR54","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1038\/s41591-023-02612-0","volume":"29","author":"A Mackensen","year":"2023","unstructured":"Mackensen, A. et al. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nat. Med. 29, 2844\u20132853 (2023).","journal-title":"Nat. Med."},{"key":"8033_CR55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151\u2013167 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"8033_CR56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nbt.1523","volume":"27","author":"A Gnirke","year":"2009","unstructured":"Gnirke, A. et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 27, 182\u2013189 (2009).","journal-title":"Nat. Biotechnol."},{"key":"8033_CR57","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"8033_CR58","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0221-8","volume":"7","author":"NA Miller","year":"2015","unstructured":"Miller, N. A. et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med. 7, 100 (2015).","journal-title":"Genome Med."},{"key":"8033_CR59","unstructured":"Van der Auwera, G. A. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly Media, 2020)."},{"key":"8033_CR60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"8033_CR61","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987\u20132993 (2011).","journal-title":"Bioinformatics"},{"key":"8033_CR62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"8033_CR63","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"8033_CR64","doi-asserted-by":"crossref","unstructured":"Khanna, A. et al. Bam-readcount\u2014rapid generation of basepair-resolution sequence metrics. J. Open Source Softw. 7, 3722 (2022).","DOI":"10.21105\/joss.03722"},{"key":"8033_CR65","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"8033_CR66","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"8033_CR67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta, M. & Nielsen, M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32, 511\u2013517 (2016).","journal-title":"Bioinformatics"},{"key":"8033_CR68","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","volume":"19","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B. et al. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. J. Proteome Res. 19, 2304\u20132315 (2020).","journal-title":"J. Proteome Res."},{"key":"8033_CR69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","volume":"10","author":"M Nielsen","year":"2009","unstructured":"Nielsen, M. & Lund, O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 10, 296 (2009).","journal-title":"BMC Bioinformatics"},{"key":"8033_CR70","doi-asserted-by":"crossref","first-page":"289ra84","DOI":"10.1126\/scitranslmed.aaa3519","volume":"7","author":"T Danino","year":"2015","unstructured":"Danino, T. et al. Programmable probiotics for detection of cancer in urine. Sci. Transl. Med. 7, 289ra84\u2013289ra84 (2015).","journal-title":"Sci. Transl. Med."},{"key":"8033_CR71","doi-asserted-by":"crossref","first-page":"eaax0876","DOI":"10.1126\/scitranslmed.aax0876","volume":"12","author":"CR Gurbatri","year":"2020","unstructured":"Gurbatri, C. R. et al. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci. Transl. Med. 12, eaax0876 (2020).","journal-title":"Sci. Transl. Med."},{"key":"8033_CR72","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640\u20136645 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8033_CR73","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JB.188.10.3572-3581.2006","volume":"188","author":"A Reisner","year":"2006","unstructured":"Reisner, A., Krogfelt, K. A., Klein, B. M., Zechner, E. L. & Molin, S. In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J. Bacteriol. 188, 3572\u20133581 (2006).","journal-title":"J. Bacteriol."},{"key":"8033_CR74","doi-asserted-by":"crossref","first-page":"635825","DOI":"10.3389\/fimmu.2021.635825","volume":"12","author":"E Boero","year":"2021","unstructured":"Boero, E. et al. Use of flow cytometry to evaluate phagocytosis of Staphylococcus aureus by human neutrophils. Front. Immunol. 12, 635825 (2021).","journal-title":"Front. Immunol."},{"key":"8033_CR75","first-page":"14.1.1","volume":"Chapter 14","author":"X Zhang","year":"2008","unstructured":"Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, 14.1.1\u201314.1.14 (2008).","journal-title":"Curr. Protoc. Immunol."},{"key":"8033_CR76","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693\u20131702 (1992).","journal-title":"J. Exp. Med."},{"key":"8033_CR77","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/nprot.2007.296","volume":"2","author":"BJC Quah","year":"2007","unstructured":"Quah, B. J. C., Warren, H. S. & Parish, C. R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2, 2049\u20132056 (2007).","journal-title":"Nat. Protoc."},{"key":"8033_CR78","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/iai.56.4.766-772.1988","volume":"56","author":"J Mengaud","year":"1988","unstructured":"Mengaud, J. et al. Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect. Immun. 56, 766\u2013772 (1988).","journal-title":"Infect. Immun."},{"key":"8033_CR79","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","volume":"515","author":"MM Gubin","year":"2014","unstructured":"Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577\u2013581 (2014).","journal-title":"Nature"},{"key":"8033_CR80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm.3105","volume":"19","author":"Y Hailemichael","year":"2013","unstructured":"Hailemichael, Y. et al. Persistent antigen at vaccination sites induces tumor-specific CD8+T\u00a0cell sequestration, dysfunction and deletion. Nat. Med. 19, 465\u2013472 (2013).","journal-title":"Nat. Med."},{"key":"8033_CR81","doi-asserted-by":"crossref","first-page":"e11867","DOI":"10.1371\/journal.pone.0011867","volume":"5","author":"X Fu","year":"2010","unstructured":"Fu, X. et al. A simple and sensitive method for measuring tumor-specific T cell cytotoxicity. PLoS ONE 5, e11867 (2010).","journal-title":"PLoS ONE"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08033-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T17:04:08Z","timestamp":1731517448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08033-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":81,"journal-issue":{"issue":"8038","published-print":{"date-parts":[[2024,11,14]]}},"alternative-id":["8033"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-08033-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.29.560228","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R., J.I., T.D. and N.A. have filed a provisional patent application with the US Patent and Trademark Office related to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}